Skip to content

Clinical Investigation and Molecular Forms of Family Disease of Varicose

Genetic Study of Varicose Disease by Sequencing Exome

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02870127
Enrollment
430
Registered
2016-08-17
Start date
2013-06-01
Completion date
2016-12-19
Last updated
2019-04-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Varicose Veins

Brief summary

The existence of a family factor in the genesis of varicose veins is certain, but few studies have addressed reliably instead of the genetic factor in clinical and molecular level. The investigator initiated an original study to identify one or more genetic abnormalities predisposing to varicose disease, based on a combined approach of genetic linkage and of exome sequencing. The clinical research phase is an essential prerequisite to the identification of genetic mutations; it is to identify large affected families and ensure an extremely rigorous and accurate phenotyping of individuals over several generations. A first clinical work has identified and / or phenotype 8 families with a genetically informative family suggesting autosomal dominant inheritance. Linkage analysis suggested several candidate chromosomal regions without allowing the identification of a gene. This project aims to resume and expand the Family clinical investigations and apply the techniques of genome analysis points, including exome sequencing on the most informative families to identify the genes and mechanisms responsible of this disease and improve the prevention and the treatment of varicose veins.

Interventions

OTHERblood sample

Sponsors

Direction Générale de l'Offre de Soins
CollaboratorOTHER_GOV
Nantes University Hospital
Lead SponsorOTHER

Study design

Observational model
FAMILY_BASED
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
25 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Any patient consultant the Medicine Vascular Surgery for varicose veins of the lower limbs as part of a manifesto family context * Varices Presence in at least one family member * Written consent

Exclusion criteria

* Patients who are unable to sign or who refuse to sign an informed consent * Subjects aged less than 25 years, due to the low penetrance of varicose disease that age. * Secondary veins at a post-thrombotic disease (suspected by the examination and confirmed by Doppler ultrasonography of the deep venous system) * Venous angiodysplasia or secondary varicose arteriovenous fistulas.

Design outcomes

Primary

MeasureTime frame
genetic abnormalities segregating with the presence of varicose veins in the informative families recruited.year 4

Secondary

MeasureTime frameDescription
genotype/phenotype relationshipyear 4improving knowledge of the genotype / phenotype based on genes identified in different families.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026